Quarterly RTA certificate under SEBI Depositories Regulations filed

Compliance View source PDF Explain this filing

SUVEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.7%Reaction day

₹310.75

prior close

₹307.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-1.4% vs market

Healthcare Research Analytics & Technology peers, median of 5sector+0.9%-2.6% vs sector

On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 2.6 pts less than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.3

10m

-0.4

15m

-0.3

30m

-0.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.7-0.2-1.4+0.9-2.6

Next day

-7.5-3.0-4.6-1.9-5.7

-8.7-2.7-6.0-2.3-6.4

-8.3-1.9-6.4-0.9-7.3

-8.6-1.7-6.8-2.9-5.6

-6.7-1.0-5.6-1.2-5.5

-1.9-2.0+0.1+0.2-2.1

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Research Analytics & Technology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Suven Life Sciences has submitted a quarterly certificate from its Registrar and Share Transfer Agent, KFin Technologies, under Regulation 74(5) of SEBI Depositories Regulations 2018. The certificate, dated 1 October 2026, covers the quarter ended 30 September 2026 and confirms that details of shares dematerialised and rematerialised during the period have been furnished to BSE and NSE. The filing was made on 7 October 2026 by the Company Secretary.

Likely market impact

Routine regulatory compliance filing. No material impact on shareholders or stock price.